Paul Lephart
Impact in
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- Antibiotic Use and Resistance 19
-
- Antibiotic Resistance in Bacteria 25
- Co-authors
- Keith S. KayeJason M. PogueTeena ChopraHossein SalimniaDror MarchaimKayoko HayakawaJingjing ZhaoJaewon Lee
- Journals
- American Journal of Infection Control (9 papers)Open Forum Infectious Diseases (8 papers)Infection Control and Hospital Epidemiology (7 papers)Journal of Clinical Microbiology (5 papers)Antimicrobial Agents and Chemotherapy (5 papers)
- Partner nations
- United StatesIsraelJapan
In The Last Decade
Paul Lephart
71 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 116
- Molecular Medicine 941
- Applied Microbiology and Biotechnology 343
- Clinical Biochemistry 551
- Infectious Diseases 947
- Endocrinology 242
Countries citing papers authored by Paul Lephart
This map shows the geographic impact of Paul Lephart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Lephart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Lephart more than expected).
Fields of papers citing papers by Paul Lephart
This network shows the impact of papers produced by Paul Lephart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Lephart. The network helps show where Paul Lephart may publish in the future.
Co-authors
The 25 scholars most cited alongside Paul Lephart, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 0 | |
| 4 | 2021 | 10 | |
| 5 | 2020 | 6 | |
| 6 | 2020 | 37 | |
| 7 | 2019 | 6 | |
| 8 | 2017 | 3 | |
| 9 | 2015 | 18 | |
| 10 | 2015 | 128 | |
| 11 | 2014 | 76 | |
| 12 | 2014 | 52 | |
| 13 | 2014 | 41 | |
| 14 | 2013 | 6 | |
| 15 | 2013 | 27 | |
| 16 | 2013 | 128 | |
| 17 | 2012 | 22 | |
| 18 | 2012 | 14 | |
| 19 | 2011 | 279 | |
| 20 | 2004 | 7 |
About Paul Lephart
Paul Lephart is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine, Clinical Biochemistry, Infectious Diseases and Epidemiology, having authored 75 papers that have together received 2.4k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (25 papers), Bacterial Identification and Susceptibility Testing (24 papers), Antibiotic Use and Resistance (19 papers), Antibiotics Pharmacokinetics and Efficacy (12 papers), Antimicrobial Resistance in Staphylococcus (12 papers), Clostridium difficile and Clostridium perfringens research (8 papers), Respiratory viral infections research (8 papers) and Fungal Infections and Studies (7 papers). The work is most often cited by research in Molecular Medicine (941 citations), Applied Microbiology and Biotechnology (343 citations), Clinical Biochemistry (551 citations), Infectious Diseases (947 citations) and Endocrinology (242 citations). Paul Lephart has collaborated with scholars based in United States, Israel and Japan. Frequent co-authors include Keith S. Kaye, Jason M. Pogue, Teena Chopra, Hossein Salimnia, Dror Marchaim, Kayoko Hayakawa, Dror Marchaim, Jingjing Zhao, Jaewon Lee and Victoria J. Yee. Their work appears in journals such as American Journal of Infection Control, Open Forum Infectious Diseases, Infection Control and Hospital Epidemiology, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.